lung cancer pathogensis - genetic & pathways
Jump to navigation
Jump to search
Introduction
- c-myc
- K-ras mutations (~15-20% non small cell carcinomas, not small cell carcinoma)
Overexpressed proteins:
- p53 (~90% small cell carcinoma, ~50% non small cell carcinoma)
- Rb (~90% small cell carcinoma, ~20% non small cell carcinoma)
- p16 (<1% small cell carcinoma, >50% non small cell carcinoma)
Other less frequently involved: FHIT, RASFF1A, SEMA3B, PTEN, hOGG1, BAP1
Additional terms
References
- ↑ Minna et al. Cancer Cell 1: 49-52, 2002